Latest in Cardiology from ACC.org

• ACCEL Lite: The Power of Nutrition: GOFRESH Trial
  In this interview, Cindy L. Grines MD, FACC and Stephen Juraschek, MD, PhD discuss how findings from the GOFRESH trial may be used to improve hypertension management and overall patient care.
• Urgent AFib Ablation Associated With Greater Risk of In-Hospital Complications | NCDR Study
  The rate of urgent atrial fibrillation (AFib) ablation has increased over time, and patients undergoing urgent vs. elective AFib ablation are more likely to have comorbidities like diabetes, coronary artery disease (CAD) and heart failure (HF) and have in-hospital complications...
• When Biology Improves But Patients Do Not: Interpreting the ODYSSEY-HCM Findings
  Patients with nonobstructive hypertrophic cardiomyopathy (nHCM) often present with symptoms and physiology resembling heart failure with preserved ejection fraction: exertional dyspnea, limited exercise capacity, chronotropic incompetence, microvascular ischemia, diastolic dysfunction, and a small, stiff left ventricular (LV) cavity.
• Key Insights From the ANDES Trial: DOAC vs. DAPT After Left Atrial Appendage Closure
  The ANDES (Antithrombotic Therapy After Left Atrial Appendage Closure: Direct Oral Anticoagulants vs Dual Antiplatelet Therapy) trial results demonstrated that, in patients with nonvalvular atrial fibrillation who underwent left atrial appendage closure (LAAC), short-term direct oral anticoagulant (DOAC) therapy...
• ACC Featured Jobs For March 2026
  Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career!